NCT00357396 2015-11-25
Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
1 trialsHas results × Neuroectodermal Tumors, Primitive, Peripheral × Peripheral Blood Stem Cell Transplantation × Clear all